224 related articles for article (PubMed ID: 22163125)
1. The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.
Zhao B; Li J; Luo X; Zhou Q; Chen H; Shi H
Tex Heart Inst J; 2011; 38(5):516-22. PubMed ID: 22163125
[TBL] [Abstract][Full Text] [Related]
2. Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction.
Sgueglia GA; Niccoli G; Spaziani C; Cosentino N; Russo E; Andreotti F; Lanza GA; Landolfi R; Crea F
Int J Cardiol; 2010 Nov; 145(2):230-232. PubMed ID: 19732980
[TBL] [Abstract][Full Text] [Related]
3. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
[TBL] [Abstract][Full Text] [Related]
5. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
[TBL] [Abstract][Full Text] [Related]
6. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
7. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
[TBL] [Abstract][Full Text] [Related]
8. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
10. Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention.
Chen Y; Wang C; Yang X; Wang L; Sun Z; Liu H; Chen L
Heart Vessels; 2012 May; 27(3):243-9. PubMed ID: 21526420
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between post-stenting coronary thrombolysis in myocardial infarction flow and plasma von Willebrand factor and ADAMTS-13 levels in patients with ST segment elevation myocardial infarction].
Zhou Q; Li J; Luo XP; Shi HM; Chen H; Zhao BL; Zhu J; Ni HC; Shen W; Wang CP
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):212-6. PubMed ID: 21609524
[TBL] [Abstract][Full Text] [Related]
12. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
Niccoli G; Cosentino N; Lombardo A; Sgueglia GA; Spaziani C; Fracassi F; Cataneo L; Minelli S; Burzotta F; Maria Leone A; Porto I; Trani C; Crea F
Coron Artery Dis; 2011 Nov; 22(7):507-14. PubMed ID: 21857508
[TBL] [Abstract][Full Text] [Related]
13. Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.
Ozawa K; Packwood W; Varlamov O; Qi Y; Xie A; Wu MD; Ruggeri Z; López JA; Lindner JR
Circ Cardiovasc Imaging; 2018 Nov; 11(11):e007913. PubMed ID: 30571316
[TBL] [Abstract][Full Text] [Related]
14. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
[TBL] [Abstract][Full Text] [Related]
15. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
Şen Ö; Şen SB; Topuz AN; Topuz M
Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
[No Abstract] [Full Text] [Related]
17. The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
Eerenberg ES; Teunissen PF; van den Born BJ; Meijers JC; Hollander MR; Jansen M; Tijssen R; Beliën JA; van de Ven PM; Aly MF; Kamp O; Niessen HW; Kamphuisen PW; Levi M; van Royen N
Cardiovasc Res; 2016 Aug; 111(3):194-203. PubMed ID: 27174213
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
19. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
[TBL] [Abstract][Full Text] [Related]
20. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
